Literature DB >> 17395679

Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM).

Hans D Theiss1, Robert David, Markus G Engelmann, Andreas Barth, Klaus Schotten, Michael Naebauer, Bruno Reichart, Gerhard Steinbeck, Wolfgang-M Franz.   

Abstract

AIMS: This study aimed at analysing the endogenous stem cell circulation in patients suffering from idiopathic dilated cardiomyopathy (DCM) and ischaemic cardiomyopathy (ICM). METHODS AND
RESULTS: Cytokines in peripheral blood were analysed using enzyme-linked immunosorbent assay and circulating CD34(+) stem cell populations (CD34(+)CD133(+), CD34(+)CD31(+), CD34(+)CXCR-4(+)) were measured by flow cytometry in DCM patients (n = 25), ICM patients (n = 15), and controls (n = 10). Explanted DCM (n = 5), ICM (n = 4) and normal hearts (n = 5) were analysed for the expression of several homing factors [stromal cell-derived factor-1 (SDF-1), Stem cell factor (SCF), HIF-1a, vascular cell adhesion molecule (VCAM), and Hepatocyte growth factor] by quantitative real-time polymerase chain reaction (PCR). SDF-1 was significantly elevated and positively correlated with brain natriuretic peptide (BNP) in peripheral blood of DCM and ICM patients showing the same New York heart association- (NYHA) class. In DCM patients circulating CD34(+) cell populations were significantly increased in comparison to ICM patients and controls. mRNA of SDF-1, SCF, HIF-1a, and VCAM related to glyceraldehyde-3-phosphate dehydrogenase was significantly upregulated in ICM hearts when compared with DCM hearts and controls.
CONCLUSION: Myocardial homing factors are upregulated in ICM when compared with DCM hearts. Reduced homing of stem cells might therefore explain the increased number of CD34(+) cells in DCM patients. These findings may open a new insight into the pathology and the treatment of idiopathic DCM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395679     DOI: 10.1093/eurheartj/ehm011

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  29 in total

Review 1.  Intramyocardial navigation and mapping for stem cell delivery.

Authors:  Peter J Psaltis; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-23       Impact factor: 4.132

2.  Aging is not associated with bone marrow-resident progenitor cell depletion.

Authors:  Thomas J Povsic; Jiying Zhou; Stacie D Adams; Michael P Bolognesi; David E Attarian; Eric D Peterson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-30       Impact factor: 6.053

3.  Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy.

Authors:  Peter J Psaltis; Angelo Carbone; Darryl P Leong; Dennis H Lau; Adam J Nelson; Tim Kuchel; Troy Jantzen; Jim Manavis; Kerry Williams; Prashanthan Sanders; Stan Gronthos; Andrew C W Zannettino; Stephen G Worthley
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-29       Impact factor: 2.357

4.  Left ventricular mass and progenitor cells in chronic heart failure patients.

Authors:  Antonio Michelucci; Francesca Cesari; Giuseppe Ricciardi; Paola Attanà; Paolo Pieragnoli; Francesca Ristalli; Luigi Padeletti; Anna Maria Gori; Gian Franco Gensini; Rosanna Abbate
Journal:  Intern Emerg Med       Date:  2014-11-12       Impact factor: 3.397

5.  Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

Authors:  Ayman Samman Tahhan; Muhammad Hammadah; Pratik B Sandesara; Salim S Hayek; Andreas P Kalogeropoulos; Ayman Alkhoder; Heval Mohamed Kelli; Matthew Topel; Nima Ghasemzadeh; Kaavya Chivukula; Yi-An Ko; Hiroshi Aida; Iraj Hesaroieh; Ernestine Mahar; Jonathan H Kim; Peter Wilson; Leslee Shaw; Viola Vaccarino; Edmund K Waller; Arshed A Quyyumi
Journal:  Circ Heart Fail       Date:  2017-08-08       Impact factor: 8.790

6.  Circulating Endothelial Progenitor Cells: Potential Biomarkers for Idiopathic Dilated Cardiomyopathy.

Authors:  Santiago Roura; Carolina Gálvez-Montón; Marco A Fernández; Josep Lupón; Antoni Bayes-Genis
Journal:  J Cardiovasc Transl Res       Date:  2016-01-06       Impact factor: 4.132

Review 7.  Vascular dysfunction in idiopathic dilated cardiomyopathy.

Authors:  Santiago Roura; Antoni Bayes-Genis
Journal:  Nat Rev Cardiol       Date:  2009-07-28       Impact factor: 32.419

8.  Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair.

Authors:  Ke Cheng; Konstantinos Malliaras; Rachel Ruckdeschel Smith; Deliang Shen; Baiming Sun; Agnieszka Blusztajn; Yucai Xie; Ahmed Ibrahim; Mohammad Amin Aminzadeh; Weixin Liu; Tao-Sheng Li; Michele A De Robertis; Linda Marbán; Lawrence S C Czer; Alfredo Trento; Eduardo Marbán
Journal:  JACC Heart Fail       Date:  2014-02       Impact factor: 12.035

9.  Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance.

Authors:  Bojan Vrtovec; Matjaz Sever; Mojca Jensterle; Gregor Poglajen; Andrej Janez; Nika Kravos; Gregor Zemljic; Marko Cukjati; Peter Cernelc; François Haddad; Joseph C Wu; Ulrich P Jorde
Journal:  Stem Cells Transl Med       Date:  2016-03-29       Impact factor: 6.940

10.  Combined intermittent hypoxia and surface muscle electrostimulation as a method to increase peripheral blood progenitor cell concentration.

Authors:  Ginés Viscor; Casimiro Javierre; Teresa Pagès; Josep-Lluis Ventura; Antoni Ricart; Gregorio Martin-Henao; Carmen Azqueta; Ramon Segura
Journal:  J Transl Med       Date:  2009-10-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.